Kochanczyk T, Fishman M, Lima C
Chembiochem. 2024; 26(1):e202400659.
PMID: 39313481
PMC: 11727022.
DOI: 10.1002/cbic.202400659.
Guo C, Liu X, Qiu K, Tu L, Liu D
Clin Cosmet Investig Dermatol. 2024; 17:1387-1404.
PMID: 38881700
PMC: 11180437.
DOI: 10.2147/CCID.S460845.
Wang Y, Wu Z, Wang C, Wu N, Wang C, Hu S
Mol Cell Biochem. 2024; 479(11):2907-2919.
PMID: 38252355
DOI: 10.1007/s11010-023-04917-7.
Tessier T, Chowdhury A, Stekel Z, Fux J, Sartori M, Teyra J
Protein Sci. 2023; 33(2):e4885.
PMID: 38147466
PMC: 10823456.
DOI: 10.1002/pro.4885.
Lai X, Lui S, Lam H, Adachi Y, Sim W, Vasilevski N
NPJ Precis Oncol. 2023; 7(1):136.
PMID: 38102334
PMC: 10724235.
DOI: 10.1038/s41698-023-00486-6.
Structure of the human UBR5 E3 ubiquitin ligase.
Wang F, He Q, Zhan W, Yu Z, Finkin-Groner E, Ma X
Structure. 2023; 31(5):541-552.e4.
PMID: 37040767
PMC: 10403316.
DOI: 10.1016/j.str.2023.03.010.
Roles of TGF‑β signalling pathway‑related lncRNAs in cancer (Review).
Hu Z, Liu Y, Liu M, Zhang Y, Wang C
Oncol Lett. 2023; 25(3):107.
PMID: 36817052
PMC: 9932718.
DOI: 10.3892/ol.2023.13693.
Exploiting the Endogenous Ubiquitin Proteasome System in Targeted Cancer Treatment.
Hauser N, Hirbawi J, Saban Golub M, Zabit S, Lichtenstein M, Lorberboum-Galski H
Cancers (Basel). 2023; 15(1).
PMID: 36612252
PMC: 9818074.
DOI: 10.3390/cancers15010256.
Redefining the catalytic HECT domain boundaries for the HECT E3 ubiquitin ligase family.
Kane E, Beasley S, Schafer J, Bohl J, Lee Y, Rich K
Biosci Rep. 2022; 42(10).
PMID: 36111624
PMC: 9547173.
DOI: 10.1042/BSR20221036.
Smurf2 suppresses the metastasis of hepatocellular carcinoma via ubiquitin degradation of Smad2.
Song D, Li S, Ning L, Zhang S, Cai Y
Open Med (Wars). 2022; 17(1):384-396.
PMID: 35509688
PMC: 8874264.
DOI: 10.1515/med-2022-0437.
A GID E3 ligase assembly ubiquitinates an Rsp5 E3 adaptor and regulates plasma membrane transporters.
Langlois C, Beier V, Karayel O, Chrustowicz J, Sherpa D, Mann M
EMBO Rep. 2022; 23(6):e53835.
PMID: 35437932
PMC: 9171410.
DOI: 10.15252/embr.202153835.
Structural Diversity of Ubiquitin E3 Ligase.
Toma-Fukai S, Shimizu T
Molecules. 2021; 26(21).
PMID: 34771091
PMC: 8586995.
DOI: 10.3390/molecules26216682.
Proteasomal Degradation of Zn-Dependent Hdacs: The E3-Ligases Implicated and the Designed Protacs That Enable Degradation.
Marquez-Cantudo L, Ramos A, Coderch C, de Pascual-Teresa B
Molecules. 2021; 26(18).
PMID: 34577077
PMC: 8467390.
DOI: 10.3390/molecules26185606.
HERC5 and the ISGylation Pathway: Critical Modulators of the Antiviral Immune Response.
Mathieu N, Paparisto E, Barr S, Spratt D
Viruses. 2021; 13(6).
PMID: 34207696
PMC: 8228270.
DOI: 10.3390/v13061102.
Exploring the Roles of HERC2 and the NEDD4L HECT E3 Ubiquitin Ligase Subfamily in p53 Signaling and the DNA Damage Response.
Mathieu N, Levin R, Spratt D
Front Oncol. 2021; 11:659049.
PMID: 33869064
PMC: 8044464.
DOI: 10.3389/fonc.2021.659049.
Posttranslational Modifications of Smurfs: Emerging Regulation in Cancer.
Yang L, Zhou W, Lin H
Front Oncol. 2021; 10:610663.
PMID: 33718111
PMC: 7950759.
DOI: 10.3389/fonc.2020.610663.
SMAD-specific E3 ubiquitin ligase 2 promotes angiogenesis by facilitating PTX3 degradation in MSCs from patients with ankylosing spondylitis.
Ma M, Yang W, Cai Z, Wang P, Li H, Mi R
Stem Cells. 2021; 39(5):581-599.
PMID: 33547700
PMC: 8248389.
DOI: 10.1002/stem.3332.
Regulation of TGFβ/SMAD signaling by long non-coding RNAs in different cancers: Dark Knight in the Castle of molecular oncology.
Adylova A, Mukhanbetzhanovna A, Attar R, Yulaevna I, Farooqi A
Noncoding RNA Res. 2021; 6(1):23-28.
PMID: 33511320
PMC: 7814108.
DOI: 10.1016/j.ncrna.2020.12.003.
Development and characterisation of SMURF2-targeting modifiers.
Manikoth Ayyathan D, Levy-Cohen G, Shubely M, Boutros-Suleiman S, Lepechkin-Zilbermintz V, Shokhen M
J Enzyme Inhib Med Chem. 2021; 36(1):401-409.
PMID: 33430646
PMC: 7808752.
DOI: 10.1080/14756366.2020.1871337.
Adaptors as the regulators of HECT ubiquitin ligases.
Shah S, Kumar S
Cell Death Differ. 2021; 28(2):455-472.
PMID: 33402750
PMC: 7862271.
DOI: 10.1038/s41418-020-00707-6.